vs
BALCHEM CORP（BCPC）与Perimeter Solutions, Inc.（PRM）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是Perimeter Solutions, Inc.的2.6倍（$263.6M vs $102.8M）。BALCHEM CORP净利率更高（14.9% vs -136.5%，领先151.4%）。Perimeter Solutions, Inc.同比增速更快（19.2% vs 9.8%）。过去两年Perimeter Solutions, Inc.的营收复合增速更高（31.9% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Perimeter Solutions是一家以色列云与网络安全企业，专为各类机构打造基于零信任架构的安全远程网络方案，其技术可替代VPN、防火墙等传统安全硬件设备，助力企业简化网络安全部署，提升远程访问的安全性与效率。
BCPC vs PRM — 直观对比
营收规模更大
BCPC
是对方的2.6倍
$102.8M
营收增速更快
PRM
高出9.3%
9.8%
净利率更高
BCPC
高出151.4%
-136.5%
两年增速更快
PRM
近两年复合增速
4.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $102.8M |
| 净利润 | $39.2M | $-140.2M |
| 毛利率 | 35.6% | 45.2% |
| 营业利润率 | 19.8% | -160.7% |
| 净利率 | 14.9% | -136.5% |
| 营收同比 | 9.8% | 19.2% |
| 净利润同比 | 16.8% | -197.3% |
| 每股收益（稀释后） | $1.21 | $-0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCPRM
| Q4 25 | $263.6M | $102.8M | ||
| Q3 25 | $267.6M | $315.4M | ||
| Q2 25 | $255.5M | $162.6M | ||
| Q1 25 | $250.5M | $72.0M | ||
| Q4 24 | $240.0M | $86.2M | ||
| Q3 24 | $239.9M | $288.4M | ||
| Q2 24 | $234.1M | $127.3M | ||
| Q1 24 | $239.7M | $59.0M |
净利润BCPCPRM
| Q4 25 | $39.2M | $-140.2M | ||
| Q3 25 | $40.3M | $-90.7M | ||
| Q2 25 | $38.3M | $-32.2M | ||
| Q1 25 | $37.1M | $56.7M | ||
| Q4 24 | $33.6M | $144.2M | ||
| Q3 24 | $33.8M | $-89.2M | ||
| Q2 24 | $32.1M | $21.6M | ||
| Q1 24 | $29.0M | $-82.6M |
毛利率BCPCPRM
| Q4 25 | 35.6% | 45.2% | ||
| Q3 25 | 35.7% | 63.1% | ||
| Q2 25 | 36.4% | 62.4% | ||
| Q1 25 | 35.2% | 39.1% | ||
| Q4 24 | 36.0% | 48.6% | ||
| Q3 24 | 35.6% | 62.8% | ||
| Q2 24 | 35.5% | 57.6% | ||
| Q1 24 | 34.0% | 35.1% |
营业利润率BCPCPRM
| Q4 25 | 19.8% | -160.7% | ||
| Q3 25 | 20.4% | -27.7% | ||
| Q2 25 | 20.1% | -16.1% | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 19.8% | 71.1% | ||
| Q3 24 | 20.0% | -12.2% | ||
| Q2 24 | 19.6% | 35.4% | ||
| Q1 24 | 17.4% | -126.8% |
净利率BCPCPRM
| Q4 25 | 14.9% | -136.5% | ||
| Q3 25 | 15.1% | -28.7% | ||
| Q2 25 | 15.0% | -19.8% | ||
| Q1 25 | 14.8% | 78.7% | ||
| Q4 24 | 14.0% | 167.2% | ||
| Q3 24 | 14.1% | -30.9% | ||
| Q2 24 | 13.7% | 17.0% | ||
| Q1 24 | 12.1% | -139.8% |
每股收益（稀释后）BCPCPRM
| Q4 25 | $1.21 | $-0.89 | ||
| Q3 25 | $1.24 | $-0.62 | ||
| Q2 25 | $1.17 | $-0.22 | ||
| Q1 25 | $1.13 | $0.36 | ||
| Q4 24 | $1.03 | $1.00 | ||
| Q3 24 | $1.03 | $-0.61 | ||
| Q2 24 | $0.98 | $0.14 | ||
| Q1 24 | $0.89 | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $325.9M |
| 总债务越低越好 | — | $669.1M |
| 股东权益账面价值 | $1.3B | $1.1B |
| 总资产 | $1.7B | $2.7B |
| 负债/权益比越低杠杆越低 | — | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资BCPCPRM
| Q4 25 | $74.6M | $325.9M | ||
| Q3 25 | $65.1M | $340.6M | ||
| Q2 25 | $65.4M | $140.7M | ||
| Q1 25 | $49.9M | $200.1M | ||
| Q4 24 | $49.5M | $198.5M | ||
| Q3 24 | $73.7M | $223.1M | ||
| Q2 24 | $63.7M | $43.2M | ||
| Q1 24 | $60.3M | $38.7M |
总债务BCPCPRM
| Q4 25 | — | $669.1M | ||
| Q3 25 | — | $668.8M | ||
| Q2 25 | — | $668.4M | ||
| Q1 25 | — | $668.1M | ||
| Q4 24 | — | $667.8M | ||
| Q3 24 | — | $667.4M | ||
| Q2 24 | — | $667.1M | ||
| Q1 24 | — | $666.8M |
股东权益BCPCPRM
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.1B | $1.1B |
总资产BCPCPRM
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.7B | $2.5B | ||
| Q1 25 | $1.6B | $2.4B | ||
| Q4 24 | $1.6B | $2.4B | ||
| Q3 24 | $1.6B | $2.5B | ||
| Q2 24 | $1.6B | $2.3B | ||
| Q1 24 | $1.6B | $2.3B |
负债/权益比BCPCPRM
| Q4 25 | — | 0.59× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $18.6M |
| 自由现金流经营现金流 - 资本支出 | — | $11.6M |
| 自由现金流率自由现金流/营收 | — | 11.3% |
| 资本支出强度资本支出/营收 | — | 6.8% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $208.6M |
8季度趋势，按日历期对齐
经营现金流BCPCPRM
| Q4 25 | $67.3M | $18.6M | ||
| Q3 25 | $65.6M | $198.7M | ||
| Q2 25 | $47.3M | $-2.9M | ||
| Q1 25 | $36.5M | $23.7M | ||
| Q4 24 | $52.3M | $-6.0M | ||
| Q3 24 | $51.3M | $183.0M | ||
| Q2 24 | $45.0M | $8.6M | ||
| Q1 24 | $33.4M | $2.8M |
自由现金流BCPCPRM
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $193.6M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | — | $179.1M | ||
| Q2 24 | — | $5.0M | ||
| Q1 24 | — | $1.2M |
自由现金流率BCPCPRM
| Q4 25 | — | 11.3% | ||
| Q3 25 | — | 61.4% | ||
| Q2 25 | — | -9.6% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | -14.4% | ||
| Q3 24 | — | 62.1% | ||
| Q2 24 | — | 3.9% | ||
| Q1 24 | — | 2.1% |
资本支出强度BCPCPRM
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 2.6% |
现金转化率BCPCPRM
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | 0.42× | ||
| Q4 24 | 1.56× | -0.04× | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | 0.40× | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
PRM
| Products | $87.7M | 85% |
| Service And Other | $14.8M | 14% |
